Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


High-Dose CoQ10 Research Urged In UCSD Early Parkinson’s Study

This article was originally published in The Tan Sheet

Executive Summary

Early-stage Parkinson's disease patients given 1,200 mg/day coenzyme Q10 experienced slower disease progression than those receiving 300 mg/d, 600 mg/d or placebo, a recent Phase II study found

You may also be interested in...

CoQ10 Early-Stage Parkinson's Disease Trial Nearing Completion

A prospective, randomized, double-blind clinical trial examining coenzyme Q10's effectiveness at treating Parkinson's disease will be completed this month, with results slated for release at the end of the year.

Enzymatic Therapy

Three products added to firm's heart health line, including Vitaline CoQ10, Vitaline L-Carnitine and Eskimo 3, a fish oil supplement. Line also includes Heart Health Formula, Formula to Retain Healthy Cholesterol Levels and Allicin 5000, a once-a-day garlic supplement. Updated packaging for the line features guidelines to help consumers determine their own dosage level. A print ad campaign for Vitaline CoQ10 is scheduled to begin in May and will run through year end. A 30-count of 100 mg Vitaline CoQ10 chews in chocolate and maple flavors will retail for $34.50. A 60-count of Vitaline L-Carnitine softgels will sell for $36.95 and 105 Eskimo-3 softgels will cost $19.95

People In Brief

Perrigo promotes in pricing, planning





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts